Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Bill Could Spur Interest In Drug Comparative Effectiveness Studies

Executive Summary

Proposals to augment HHS studies comparing the effectiveness of drugs could gain ground thanks to provisions in Sen. Max Baucus' drug price negotiation legislation, regardless of the fate of price negotiation itself

You may also be interested in...



Health Plans Readying For Comparative Effectiveness Push Next Year

With drug spending on the rise, health plans expect new federal policy on comparative effectiveness is imminent.

More Research, Little Action On Comparative Effectiveness In Medicare Bill

Despite hopes that research on the comparative effectiveness of health services could both improve health care quality and reduce spending, the creation of an expanded federal program remains stuck in the examination phase

More Research, Little Action On Comparative Effectiveness In Medicare Bill

Despite hopes that research on the comparative effectiveness of health services could both improve health care quality and reduce spending, the creation of an expanded federal program remains stuck in the examination phase

Related Content

UsernamePublicRestriction

Register

PS048306

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel